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Abstract 
The meniscus plays important roles in prop-
er knee function. It was recently reported that
meniscus  degeneration  was  associated  with
progression  of  osteoarthritis  (OA).  However,
little is known about the effects of degradative
enzymes  on  the  meniscus  matrix,  primarily
collagen type I and aggrecan, during OA. This
study  examined  the  effects  of  metallopro-
teinase  (MMP)  and  aggrecanase  on  the
destruction of aggrecan in the human menis-
cus.  Eighteen  trimmed  meniscus  portions
were  collected  during  partial  menisectomy.
Specimens  were  categorized  into  3  groups
according to the modified Copenhaver classifi-
cation based on the degrees of damage to col-
lagen bundles. Histological and immunohisto-
chemical  studies  were  conducted.  Sections
were stained with antibodies against MMP-3,
aggrecanase 1 and 2, and their specific cleav-
age sites of aggrecan. Their localizations and
staining  ratios  in  the  inner  superficial  and
outer deep zones of the meniscus were deter-
mined separately. The population of chondro-
cyte-like cells increased with degeneration of
the meniscus. MMP-3 and aggrecanase 1 and 2
are primarily expressed and activated in chon-
drocyte-like cells. MMP-3 expression and acti-
vation  increased  with  degeneration  and  the
population of chondrocyte-like cells. Changes
in aggrecanase 1 expression with the degener-
ation were not clearly detected, whereas the
expression  of  aggrecanase  2  was  associated
with progression of degeneration. MMP-3 and
aggrecanases,  particularly  aggrecanase  2,
expressed in chondrocyte-like cells could play
important roles in aggrecan degradation in the
human meniscus. 
Introduction 
The menisci perform several important bio-
mechanical functions in the knee. They dis-
tribute stresses over wide areas of the articu-
lar  cartilage,  absorb  shocks  during  dynamic
loading,  and  assist  in  joint  lubrication.
Furthermore,  the  menisci  are  2  crescentic
fibrocartilaginous  structures  that  serve  to
deepen the articular surface of the tibia for
reception of the femoral condyles and provide
mechanical stability in the knee.
1 Clinically, it
is well known that surgical removal of the dam-
aged parts of the meniscus causes osteoarthri-
tis (OA).
2,3 A population-based study suggested
that at least one-third of middle-aged or elder-
ly persons had meniscal damage.
4
Biochemically, approximately 65-75% of the
meniscus is water. The extracellular matrix of
the meniscus (60-70% of the dry weight) is pri-
marily composed of collagen type I; however,
types II, III, V, VI, and X have also been identi-
fied within the meniscus.
5,6 Cartilage-like pro-
teoglycan is an essential component found in
the adult human meniscus.
7 Histologically, col-
lagen bundles are arranged in a circumferen-
tial pattern that is optimal for absorption of
compressive loads. Radial fibers at the surface
and in the midsubstance running parallel to
the plateau probably increase structural rigidi-
ty and prevent longitudinal splitting.
8 The pro-
teoglycan  content  of  the  adult  meniscus  is
approximately  one-fifth  that  of  dry  articular
cartilage. Aggrecan, which is a major proteo-
glycan in the articular cartilage, is a large pro-
teoglycan that is also present in the meniscus.
6
Collagen  fibrils  provide  tensile  strength  to
maintain tissue integrity, whereas aggrecan,
interwoven  with  the  collagen  fibrils,  con-
tributes to compressive stiffness. 
It is well known that both metalloproteinas-
es  (MMPs)  and  aggrecanase  play  roles  in
aggrecan cleavage in normal as well as OA car-
tilage.
9 Cleavage  of  aggrecan  could  be  an
important and early event of cartilage matrix
degradation during OA progression. Two major
sites of enzymatic digestion have been identi-
fied within the interglobular domain between
residues  Asn
341 and  Phe342,  and  Glu
373 and
Ala374. The first site has been shown to be
cleaved by a variety of matrix MMPs, whereas
cleavage  at  the  second  site  is  catalyzed  by
aggrecanases.
10 Aggrecanase 1 and 2 are mem-
bers  of  a  disintegrin  and  metalloproteinase
with thrombospondin-like repeats (ADAM-TS)
family and have been designated as ADAM-TS
4 and ADAM-TS 5, respectively.
11
Based on a cohort study with a 3-year follow-
up  period,  it  was  recently  reported  that  the
presence of meniscal damage itself, even with-
out  surgical  removal,  was  a  significant  risk
factor  for  development  of  radiographic  OA.
These results strongly suggested the need for
understanding  the  mechanisms  of  meniscal
damage during OA development.
12 However, lit-
tle is known about matrix degradation of the
human meniscus. 
In this study, we examined the localizations
and expression of MMP-3 and aggrecanase 1
and 2 as well as their specific cleavage sites of
aggrecan in the human meniscus. To the best
of our knowledge, this is the first report on the
roles of MMP-3 and aggrecanase in degenera-
tion of the human meniscus. 
Materials and Methods
Eighteen  menisci  were  collected  from
patients aged 23-75 years (Table 1) at the time
of arthroscopic partial menisectomy in Hokuto
Hospital. Institutional approval was obtained
before  the  commencement  of  this  study.  All
patients gave informed consent for samples to
be harvested for this study. 
At  an  initial  visit,  a  detailed  history  was
taken,  and  physical  and  X-ray  photographic
examinations  (X-P)  were  performed.  Radio-
logical evaluation of the knee was performed
according to the grading system described by
Kellgren et al.
13 In cases in which torn menisci
were detected by magnetic resonance imaging,
we  performed  arthroscopic  examination  and
partial resection of the torn menisci, if needed.
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Patients  with  ligamentous  lesions,  such  as
anterior cruciate ligament (ACL) injury, were
excluded from this study. 
Evaluation of cartilage lesions was also per-
formed. Articular cartilage lesions were graded
according  to  the  Outerbridge  classification
14:
Grade 0, normal; Grade 1, articular softening or
blistering; Grade 2, articular fissures or clefts
measuring less than 1 cm in diameter; Grade
3, deep fissures extending to the subchondral
bone measuring more than 1 cm; and Grade 4,
exposed subchondral bone. The highest grade
in all cartilage surfaces was recorded as the
grade of the cartilage lesion for that patient.
During removal of the torn menisci, the por-
tion next to the lesion was removed for trim-
ming;  this  portion  was  used  for  this  study.
After removal, samples were immediately fixed
in  10%  buffered  formalin  and  embedded  in
paraffin. 
Histological evaluation 
Radial sections (4 ʼm thick) were cut from
the  embedded  samples.  Sequential  sections
were prepared for hematoxylin-eosin staining
and immunohistochemistry. The degree of his-
tological  degeneration  of  the  meniscus  was
defined according to the modified Copenhaver
classification, based on degeneration of colla-
gen bundles in the menisci.
15 This classifica-
tion  is  as  follows:  Stage  0,  homogeneous
eosinophilic staining collagen; Stage 1, mild
cleft formation of collagen bundles; and Stage
2, severe cleft and cyst formation of collagen
bundles.  We  divided  the  removed  menisci
(trimmed portions) into 3 groups based on this
histological grading system. 
Immunohistochemistry 
Antibodies 
The antibody against MMP-3 (mouse mono-
clonal)  was  purchased  from  Daiichi  Fine
Chemistry (Toyama, Japan). This antibody can
recognize both the latent and active forms of
MMP-3. Antibodies against aggrecanase 1 and
2  (rabbit  polyclonal)  were  purchased  from
Sigma (St. Louis, MO, USA). They can recog-
nize the latent and active forms of aggrecanase
1 and 2. 
Rabbit polyclonal antibodies (Bio Synthesis,
Lewisville,  TX,  USA)  were  prepared  against
neoepitopes  generated  by  MMPs  (DIPEN
341)
and aggrecanases (TEGE
373), using amino acid
sequences  (NH2-GCGEDFVDIPEN  and  NH2-
GCPLPRNITEGE, respectively) of human-spe-
cific cleavage sites. To confirm the specificity,
a binding assay to the antigen peptide for each
antibody was performed. Both antibodies had
titers up to 1:25600, which is considered excel-
lent.  Furthermore,  these  antibodies  could
detect  the  specific  cleavage  sites  extracted
from  interleukin  (IL)-1-stimulated  cartilage
explants by Western blotting, as reported previ-
ously by Tortorella et al.
11
Immunostaining 
Sections were deparaffinized and immersed
in  0.3%  hydrogen  peroxide  methanol  for  20
min. They were washed three times with phos-
phate-buffered saline (PBS) for 10 min each
time, and the sections for DIPEN
341 and TEGE
373
antibodies were permeabilized with protease-
free  chondroitinase  ABClyase  [0.5  units  per
mL in 0.1 M Tris HCL (pH 8.0) containing 0.05
M  sodium  acetate;  Seikagaku  Corporation,
Tokyo, Japan] for 30 min at 37°C. All sections
were washed three times with PBS for 5 min
each  time  and  then  permeabilized  with  1%
bovine  serum  albumin  (BSA)  for  10  min.
These were then washed three times with PBS
for 3 min each time. The sections were incu-
bated for 90 min at 37°C with serum contain-
ing either DIPEN
341 antibody (1:500 dilution of
1% BSA), TEGE
373 antibody (1:500 dilution of
1% BSA), MMP-3 antibody (1:500 dilution of
1% BSA), or aggrecanase 1 and 2 antibodies
(1:500 dilution of 1% BSA). 
After washing with PBS, sections for rabbit
polyclonal  antibodies  (DIPEN
341,  TEGE
373,  and
aggrecanase 1 and 2) were incubated for 90
min at 37°C with serum containing anti-rabbit
biotinylated secondary antibody (1:500 dilution
of 1% BSA), whereas sections for MMP-3 anti-
body were incubated for 90 min at 37°C with
serum containing anti-mouse biotinylated sec-
ondary antibody (1:500 dilution of 1% BSA).
They were then washed three times with PBS
for 5 min each time. 
Finally,  the  sections  were  immersed  in
diaminobenzidine  solution  [150  mL  0.05  M
Tris HCL (pH 7.6) containing 15 mL of 30%
hydrogen  peroxide  and  30  mg  of  3.3’-
diaminobenzidine]  for  30  min  and  washed
three times with PBS for 5 min each time. 
Statistical analysis 
There  are  2  histological  features  of  the
meniscus.  One  is  that  collagen  bundles  are
arranged differently in each zone. The majori-
ty are arranged in a circumferential pattern in
the deeper area, while radial fibers are found
at the surface. The other is that the outer zone
is vascularized, while the inner zone is non-
vascularized. Therefore, we focused on 2 areas
of  the  meniscus:  the  inner-superficial  and
outer-deeper zones. 
Mean values of the staining ratio of MMP-3
and aggrecanase 1 and 2 in cells were deter-
mined  from  2  randomly  selected  fields  of
microscopy (400x) in the inner-superficial and
outer-deeper zones, respectively. Mean values
of  the  staining  ratio  of  cleavage  sites
(DIPEN
341, TEGE
373) in the territorial and peri-
cellular regions of cells were also determined. 
For  statistical  analysis,  we  used  the  non-
parametric Kruskal-Wallis one-way analysis of
variance on ranks to compare overall differ-
ences among the 3 collagen bundle degrada-
tion groups. If this analysis showed significant
difference for a particular group, we compared
this  to  the  other  groups  using  two-tailed
Mann-Whitney U tests. A p<0.05 was consid-
ered significant. 
Results 
Clinical characteristics 
Clinical characteristics of samples are sum-
marized in Table 1. All 18 samples were from
the medial meniscus. Study subjects were 9
men and 9 women. Their mean age was 45.6
years (range, 23-75 years). The mean duration
after injury was 14.1 days (range, 3-28 days). 
Patients with more degenerative menisci in
stage  2  were  significantly  older  than  those
with menisci in stage 0. Radiographic grading
was also higher in patients with more degener-
ative menisci. More severe cartilage damage
was detected in patients with more degenera-
Article
Table 1. Patients’ clinical characteristics. 
Variables Meniscus degeneration (Copenhaver )
Stage 0 (N=6) Stage 1 (N=5) Stage 2 (N=7)
Sex Male/Female 3 / 3 3 / 2 3 / 4
Age(year) Mean (range) 29.7 (23-35) 39.8 (33-50) 63.3 (47-75)
Duration after onset  11.8 (3-20) 16.0 (4-26) 14.7 (7-28)
(day)mean (range)
X-P grade(Kellgren) Grade 0 63 0
10 2 6
20 0 1
Cartilage degeneration Grade 0 30 0
(Outerbridge) 13 3 0
2 02 1
30 0 4
40 0 2[page 12] [Orthopedic Reviews 2009; 1:e14]
tive menisci in stage 2 compared to those with
menisci in stage 0. Patients with the meniscus
in stage 2 did not experience remarkable trau-
matic events at the onset of symptoms, where-
as patients with the meniscus in stage 0 expe-
rienced traumatic events. 
Histological findings 
Two morphologically distinct populations of
cells were identified. One was a fibroblast-like
cell and the other was a chondrocyte-like cell.
Cell  density  in  both  the  inner-superficial
(p=0.006; Figure 1A) and outer-deeper zones
(p=0.007;  Figure  1B)  was  remarkably
decreased  with  these  degenerative  meniscal
changes. Proportions of chondrocyte-like cells
increased  with  these  degenerative  meniscal
changes  in  the  outer-deeper  zone  (p=0.002;
Figure 1B); there was an increasing trend in
the  inner-superficial  zone  (p=0.055;  Figure
1A). There was significant difference in the
arrangement of collagen bundles between the
superficial and deep zones, as described in the
definitions  of  menisci  degeneration.  In  the
menisci in stage 0, there were clear structural
distinctions between the superficial and deep
zones (Figure 2); however, it was difficult to
detect  these  structural  differences  between
the superficial and deep zones in the menisci
in stage 2 (Figure 3). We found that there was
more cleft and cyst formation within the colla-
gen  bundles  in  the  degenerative  meniscus.
There were some clusters consisting of chon-
drocyte-like cells in the degenerative meniscus
(Figure 3). 
Localization of degradative
enzymes MMP-3 and aggrecanase 1
and 2, and their specific cleavage sites 
Enzymes were stained mainly in the chon-
drocyte-like cells; they were less evident in the
fibroblast-like cells. Specific cleavage sites of
these enzymes were also primarily detected in
the surrounding regions (pericellular and ter-
ritorial  region)  of  chondrocyte-like  cells  but
rarely in the surrounding regions of fibroblast-
like  cells.  A  representative  case  with  the
meniscus in stage 0 is shown in Figure 2. This
case was a trimmed portion of a middle trans-
verse  tear  of  the  right  medial  meniscus
removed  from  a  26-year  old  man  with  X-P
grade  (Kellgren)  0  and  Cartilage  grade
(Outerbridge) 0. The superficial area in the
inner-superficial  zone  contained  more  chon-
drocyte-like  cells  than  the  deeper  area.  The
cleavage  site  stained  with  DIPEN
341(staining
ratio 27%) was not always colocalized with that
stained  with  MMP-3  (staining  ratio  65.5%),
whereas TEGE
373, the cleavage site of aggre-
canases  (staining  ratio  50.5%),  was  mostly
detected in the cells stained with aggrecanase
1  (staining  ratio  41%)  and  aggrecanase  2
(staining ratio 43.5%). In the menisci in stage
Article
Figure 1. Changes in cell density and population of chondrocyte- and fibroblast-like
cells. Cell count, cell/one microscopic field of 400x; % cells, percentage of the number
of chondrocyte- or fibroblast-like cell to the total number of cells.*p<0.05, Kruskal-
Wallis test. 
Figure 2. Immunostaining of the degradative enzymes and their specific cleavage sites of
aggrecan in the meniscus in stage 0. Column A. Inner-superficial zone of the meniscus
(400x) Column B. Outer-deeper zone of the meniscus (400x). Immunostaining of MMP-
3, aggrecanase 1, aggrecanase 2, DIPEN
341 (neoepitope of aggrecan generated by MMPs),
and TEGE
373 (neoepitope of aggrecan generated by aggrecanases) are shown. [Orthopedic Reviews 2009; 1:e14] [page 13]
0, the population of fibroblast-like cells in the
outer-deeper zone was greater than that in the
superficial area. The cleavage site stained with
DIPEN
341 (staining ratio 13.5%) was not often
colocalized  with  that  stained  with  MMP-3
(staining ratio 35.5%), whereas TEGE
373, the
cleavage site of aggrecanases (staining ratio
35%), was mostly detected in the cells stained
with aggrecanase 1 (staining ratio 27%) and
aggrecanase 2 (staining ratio 33%). A repre-
sentative case with the meniscus in stage 2 is
shown in Figure 3. This case was a trimmed
portion of a posterior complex tear of the right
medial meniscus removed from a 66-year old
woman  with  X-P  grade  (Kellgren)  II  and
Cartilage grade (Outerbridge) III. There were
some  clusters  in  the  inner-superficial  zone,
and the number of cells in this meniscus was
smaller than that in the meniscus in stage 0.
Most of these cells were chondrocyte-like cells.
The cleavage site stained with DIPEN
341 (stain-
ing ratio 32%) was not completely colocalized
with that stained with MMP-3 (staining ratio
58.5%),  whereas  the  cleavage  site  of  aggre-
canases (staining ratio 42%) was mostly detect-
ed  in  the  cells  stained  with  aggrecanase  1
(staining ratio 33%) and aggrecanase 2 (stain-
ing ratio 59%). There were relatively more cells
stained with aggrecanase 2 than TEGE
373. The
number and morphology of cells in the outer-
deeper zone of this meniscus was similar to that
in the inner-superficial area. The ratio of chon-
drocyte-like cells in stage 2 was greater than
that in stage 0. The cleavage site stained with
DIPEN
341 (staining ratio 34.5%) was not com-
pletely colocalized with that stained with MMP-
3 (staining ratio 58.5%), whereas TEGE
373, the
cleavage  site  of  aggrecanase  (staining  ratio
30%), was often detected in cells stained with
aggrecanase 1 (staining ratio 33%) and aggre-
canase  2  (staining  ratio  76%).  Cells  stained
with aggrecanase 2 were more frequent than
those stained with TEGE
373. 
Staining ratio of the degradative
enzymes MMP-3 and aggrecanase 1
and 2, and their specific cleavage sites 
The staining ratio of degradative enzymes
in the cells and their specific cleavage sites
around  the  cells  (territorial  and  pericellular
region) are summarized in Figures 4 and 5.
The cell staining ratio of aggrecanase 2 in the
menisci in stage 0 had greater variance com-
pared  to  that  in  stage  2  in  both  the  inner-
superficial  and  outer-deeper  zones,  whereas
the staining ratio of MMP-3 had greater vari-
ance in stage 0 compared to that in stage 2.
Aggrecanase  1  showed  no  significant  differ-
ence in variance of the staining ratio in stage
0 compared to that in stage 2. In the inner-
superficial zone, there were no significant dif-
ferences in the staining ratio of MMP-3 and
aggrecanase 1 and 2, although there was an
increasing trend in the staining ratio of MMP-
3 and aggrecanase 2 but not aggrecanase 1. In
the outer-deeper zone, we found a significant
increase in the staining ratio of MMP-3 in the
menisci in stages 1 and 2 compared to that in
the menisci in stage 0. We also found a higher
staining ratio of aggrecanase 2 in the menisci
in stage 2 than that in the menisci in stage 0
and  1.  Because  the  staining  ratio  of  aggre-
canase 2 of stage 0 in this region had large
variance, we could not find significant differ-
ences between stage 0 and stages 1. We detect-
ed a significant difference in the staining ratio
of DIPEN
341 between stage 0 and stage 1 and
also between stages 1 and 2 in the inner-super-
ficial zone. There was significant increase in
the staining ratio of DIPEN
341 in the menisci in
stages 1 and 2 compared to that in the menis-
ci  in  stage  0  in  the  outer  deeper  zone.  We
found large variances of the staining ratio of
TEGE
373 in each stage, and there were no sig-
nificant  differences  in  the  staining  ratio  of
TEGE
373 among the stage groups of the menisci
in  the  inner-superficial  zone.  In  the  outer-
deeper zone, the menisci in stage 1 had a high-
er  staining  ratio  of  TEGE
373 than  those  in
stages 0 and 2. 
Discussion 
In this study, we examined how MMP-3 and
aggrecanase  1  and  2  play  roles  in  aggrecan
degradation  in  the  human  meniscus  during
progression of degeneration. Our results indi-
cated that the expression of MMP-3 and aggre-
canase 1 and 2 and their specific cleavage sites
of  aggrecan  were  expressed  in  chondrocyte-
like  cells  and  that  this  population  of  cells
increased  with  meniscus  degeneration.  This
suggests  that  these  enzymes  play  important
roles in the cleavage of aggrecan during pro-
gression of meniscus degeneration, similar to
the progression of cartilage degradation. 
We  studied  the  expression  of  degradative
enzymes  and  their  specific  cleavage  sites
together. There are several natural inhibitors
directed against these degradative enzymes in
tissues,  such  as  tissue  inhibitors  of  matrix
Article
Figure 3. Immunostaining of the degradative enzymes and their specific cleavage sites of
aggrecan in the meniscus in stage 2. Column A. Inner-superficial zone of meniscus
(400x). Column B. Outer-deeper zone of meniscus (400x). Immunostaining of MMP-3,
aggrecanase 1, aggrecanase 2, DIPEN
341 (neoepitope of aggrecan generated by MMPs),
and TEGE373 (neoepitope of aggrecan generated by aggrecanases) are shown.[page 14] [Orthopedic Reviews 2009; 1:e14]
metalloproteinases. The mechanisms for acti-
vation of these enzymes are quite complex.
9
Therefore,  to  study  matrix  destruction,  it  is
important to study the expression of specific
cleavage sites of matrix molecules, including
aggrecan  and  collagen,  generated  by  each
degradative enzyme as well as the expression
of the enzymes themselves. 
As  the  antibodies  of  MMP-3  and  aggre-
canase 1 and 2 used in this study could recog-
nize both the latent and activated forms, there
was a difference in the staining ratio between
the enzymes and their specific cleavage sites
around the cells. We showed that expression
and  activation  of  MMP-3  were  more  pro-
nounced  in  the  outer  deeper  zones  of  the
menisci during OA progression. Of note, in the
outer-deeper zone, the staining ratio of aggre-
canase 2 increased with meniscus degenera-
tion, whereas the cleavage site (AG) signifi-
cantly decreased in the meniscus in stage 2.
When  cleavage  of  aggrecan  by  MMP-3  at
DIPEN
341 increases, the cleavage site for aggre-
canase containing TEGE
373 should be removed.
MMP-3 activation could be pronounced in the
meniscus in stage 2. 
Glasson et al.
16 reported that ADAM-TS 5 is
the  primary  aggrecanase  responsible  for
aggrecan  degradation  in  a  murine  model  of
OA. Stanton et al.
17 reported that ADAM-TS 5 is
the  major  aggrecanase  in  mouse  cartilage,
both in vitro and in a mouse model of inflam-
matory  arthritis.  Using  an  ACL  transaction
model, the levels of gene expression for aggre-
canase 1 or 2 remained remarkably stable in
both  the  cartilage  and  meniscus  during  OA
development.
18
Even in human cartilage, it is still unclear
how ADAM-TS 4 and/or ADAM-TS 5 play roles
in the degradation of aggrecan during OA pro-
gression. One study reported that aggrecanase
2 was most strongly expressed in normal and
arthritic cartilage, whereas aggrecanase 1 was
expressed only at a very low level in normal
cartilage and was only slightly upregulated in
OA  cartilage.  Furthermore,  it  has  also  been
reported that aggrecanase 1 was induced in
vitro after stimulation by IL-1ʲ, although it is
not clear whether IL-1-induced cartilage degra-
dation is a suitable model for OA.
19 Another
study showed that both cartilage aggrecanase
1 and 2 are present in osteoarthritic cartilage
of  the  knee  and  that  their  inhibition  could
block degradation in an explant culture.
20 To
explain these discrepancies, there is a possi-
bility  that  expression  of  aggrecanases  could
change during OA progression. 
Information regarding this important issue
is  much  more  limited  in  human  meniscus
studies. Interestingly, in this study, we showed
that there was no significant difference in the
expression of aggrecanase 1, in spite of the
changes  in  meniscus  degradative  grades.  In
the inner-superficial zone, the staining ratio of
TEGE
373 was higher than that of aggrecanase 1
and similar to that of aggrecanase 2, suggest-
ing that cleavage of aggrecan by aggrecanase
could  be  better  reflected  by  aggrecanase  2
expression during matrix degradation of the
human meniscus, although we could not detect
any  significant  increase  with  the  stage  of
degradation.  These  results  suggested  that
aggrecanase  1  could  be  constitutively
expressed  in  the  meniscus  and  that  aggre-
canase 2 might be inducible during the pro-
gression of matrix degradation. 
During the process of OA, matrix degrada-
tion progresses with the imbalance between
destruction and repair. In this study, we only
focused  on  degradative  enzymes  and  their
products in the menisci. The features of the
degenerative  meniscus,  including  increased
proportion of chondrocyte-like cells and cluster
formation, have been reported by a previous
study.
21 As for the features of meniscus repair,
Takeuchi  et  al.
22 reported  that  the  cells
observed in meniscal repair tissues in rabbits
initially were fibroblast-like cells, the propor-
tion of chondrocyte-like cells increased with
the advance of repair, and the repair tissue in
the  meniscus  might  have  been  hyaline-like
cartilage, which contains 5 times the amount
of  proteoglycans  than  the  meniscus.
Therefore, there is a possibility that morpho-
logical changes during OA progression could
be related to repair processes. In fact, aggrecan
cleaved by MMPs and aggrecanase were main-
ly present around these chondrocyte-like cells.
Article
Figure 4. Ratio (%) of positive staining cells of the degradative enzymes in the meniscus
of each stage. Upper, immunostaining of MMP-3; Middle, immunostaining of aggre-
canase 1; Lower, immunostaining of aggrecanase 2. p were determined by the Kruskal-
Wallis test, followed by the Mann-Whitney U test. *p<0.05.[Orthopedic Reviews 2009; 1:e14] [page 15]
Chondrocyte-like cells should be related to the
distribution  and  amount  of  aggrecan  in  the
meniscus  during  OA  progression.  Further
study on matrix synthesis is needed to under-
stand the balance between repair and destruc-
tion of the meniscus matrix during the pro-
gression of OA. 
There  are  some  limitations  in  this  study.
Although MMP-3 and aggrecanase 1 and 2 are
probably  important  enzymes  for  aggrecan
degradation,
9 there is a possibility that other
degradative  enzymes,  including  MMPs  and
aggrecanases,  play  significant  roles.  Further
studies will be required to understand the roles
of  other  enzymes  during  the  progression  of
meniscus degeneration. The sample number
was limited because of the difficulty in sam-
pling the meniscus in humans, especially the
normal meniscus. In this study, the menisci in
stage 0 had a nearly normal structure histolog-
ically. However, parts of the menisci were torn
due to trauma. The median time after injury
was 11.8 days at the sampling. This should still
be in a subacute phase. In fact, the menisci in
stage  0  had  large  variances  in  MMP-3  and
aggrecanase  2  expression,  especially  in  the
inner-superficial  zone,  and  aggrecanase  2
expression  in  the  outer-deeper  zone.  This
could  be  reflective  of  the  traumatic  events,
including bleeding, followed by acute inflam-
mation. Further studies are needed to deter-
mine  the  effects  of  inflammation,  including
cytokines, during the progression of OA. 
In  conclusion,  MMP-3  and  aggrecanase  1
and 2 are expressed and activated in the cells
of the degenerative meniscus. Based on the
changes  in  expression  and  activation  with
degeneration  of  the  meniscus,  MMP-3  and
aggrecanase  2  could  play  important  roles  in
progression  of  meniscus  degeneration.
Increased population of chondrocyte-like cells
in the human degenerative meniscus affects
aggrecan metabolism. 
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